VRX up +3.88% percent Today $VRX High is at 142.10 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 10:44 AM

VRX up +3.88% percent Today $VRX High is at 142.10 and the Low 136.96 with current volume of 1,551,346.

Recent News posted below.

Valeant Pharmaceuticals International VRX other info.
http://investorshangout.com/Valeant-Pharmaceu...VRX-53038/

VRX Valeant Pharmaceuticals International Recent Headline News

Zoetis OK's stock buyback
Seeking Alpha - at Seeking Alpha - 18 mins ago

ZTS: 43.67 (-0.56), VRX: 142.14 (+5.41)

Winners And Losers In The Allergan Valeant Actavis Melee; Also, Will Bill Ackman Lose His Profit?
Uncommon Profit Investor - at Seeking Alpha - 2 hrs 11 mins ago

AGN: 212.00 (+2.80), VRX: 142.14 (+5.41), ACT: 260.05 (+12.11)

Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation
PR Newswire - 2 hrs 43 mins ago
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Ideal Implant Incorporated today announced the receipt of approval from the U.S. Food and Drug Administration (FDA) and Health Canada to market the IDEAL IMPLANT® Saline-filled Breast Implant for use in primary breast augmentation or replacement of existing augmentation implants. The FDA approval of the IDEAL IMPLANT was based on an extensive review of various studies and data including a U.S. clinical trial that began in 2009 with 45 plastic surgeons and 502 women, who underwent breast augmentation or replacement of augmentation implants. The clinical trial is on-going and will continue to provide follow-up data through 2020.
VRX: 142.14 (+5.41), VRX.TO: 160.74 (+6.34)

Here Are Some Big Caps Poised To Make Gains
at Investor's Business Daily - Mon Nov 17, 5:45PM CST
Several Big Cap 20 stocks have recently broken out of bases, but are still within buy range, or are building new bases and could be good additions to a watch list. Alexion Pharmaceuticals (ALXN) has pulled back and is within the 5% buy zone. The...
AGN: 212.00 (+2.80), ACT: 260.07 (+12.13), VRX: 142.14 (+5.41), V: 250.17 (+0.37), ALXN: 189.99 (+3.21), CTSH: 53.00 (-0.06), MA: 83.46 (+0.26), ADS: 282.52 (+1.64)

Business Highlights
By The Associated Press - AP - Mon Nov 17, 4:57PM CST
___
VRX: 142.14 (+5.41), HAL: 49.77 (+0.54), GOOGL: 551.58 (+4.94), GOOG: 540.64 (+4.13), NRG: 31.74 (+0.06), VRX.TO: 160.74 (+6.34)

Actavis to spend $66 billion on Allergan
By TOM MURPHY - AP - Mon Nov 17, 4:01PM CST
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
1 Comment
DRTX: 24.16 (+0.41), AGN: 212.00 (+2.80), ACT: 260.07 (+12.13), VRX: 142.14 (+5.41), MRK: 59.72 (+0.26), VRX.TO: 160.74 (+6.34)

Stocks End Mixed As Allergan Jumps On Actavis Deal
at Investor's Business Daily - Mon Nov 17, 3:16PM CST
Major averages pared losses from a late-morning slump to end mixed amid big merger deals and weak economic data. The S&P 500 and Dow Jones industrial average closed fractionally higher, while the Nasdaq fell 0.4%. Volume ran lower across the board in...
AGN: 212.00 (+2.80), VRX: 142.14 (+5.41), ACT: 260.07 (+12.13), SAFM: 86.84 (+1.91), PPC: 31.29 (+0.35), MIK: 21.69 (+0.04), TSN: 42.76 (-0.27)

Stock Market Today: Japan Recession Keeps Markets From Celebrating Deals Deluge
at The Street - Mon Nov 17, 3:15PM CST
Wheelings and dealings from top pharmaceutical giants and energy companies momentarily distracts Wall Street from worrying news Japan has fallen into recession in its third quarter.
AMZN: 328.05 (+5.00), HAS: 55.99 (-0.38), ACT: 260.07 (+12.13), VRX: 142.14 (+5.41), JIVE: 6.38 (+0.01), FB: 74.39 (+0.15), HAL: 49.77 (+0.54), DWA: 22.25 (-0.06), AGN: 212.00 (+2.80), LNKD: 222.84 (-0.44), BHI: 65.95 (+0.72), CRM: 63.15 (+0.64)

Stocks Mixed In Afternoon; Allergan Jumps To New High
at Investor's Business Daily - Mon Nov 17, 2:13PM CST
Stocks remained mixed late Monday afternoon as investors weighed a spate of merger activity against news that Japan fell into a recession. The Dow Jones industrial average and the S&P 500 were each up 0.1%, while the Nasdaq was down 0.3%. Volume was...
AGN: 212.00 (+2.80), VRX: 142.14 (+5.41), ACT: 260.06 (+12.12), LNKD: 222.84 (-0.44), FB: 74.39 (+0.15), HAL: 49.77 (+0.54), BHI: 65.95 (+0.72), Z: 119.50 (+1.64)

OK, so it's not Allergan
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 12:36PM CST

VRX: 142.14 (+5.41)

Stock Market Today: Stocks Are Mixed as Corporate Deals Offset Japan's Recession
at The Street - Mon Nov 17, 12:16PM CST
Wheelings and dealings from top pharmaceutical giants and energy companies distract Wall Street from worrying news Japan had fallen into recession in its third quarter.
AGN: 212.00 (+2.80), HAS: 55.99 (-0.38), AMZN: 328.05 (+5.00), VRX: 142.14 (+5.41), ACT: 260.06 (+12.12), LNKD: 222.84 (-0.44), JIVE: 6.38 (+0.01), FB: 74.39 (+0.15), HAL: 49.78 (+0.55), DWA: 22.25 (-0.06), CRM: 63.15 (+0.64), BHI: 65.97 (+0.74)

Pershing Square wins big on Actavis buy
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 11:22AM CST

AGN: 212.00 (+2.80), ACT: 260.06 (+12.12), VRX: 142.14 (+5.41)

Today's Unusual Social Activity Stock: Valeant Pharmaceuticals International (VRX)
at The Street - Mon Nov 17, 10:36AM CST
Trade-Ideas LLC identified Valeant Pharmaceuticals International (VRX) as an unusual social activity candidate
VRX: 142.14 (+5.41)

Allergan's $66 Billion Actavis Deal is Still a Win for Bill Ackman
at The Street - Mon Nov 17, 9:59AM CST
Valeant says it can't justify $219 a share offer to shareholders.
ZTS: 43.66 (-0.57), AGN: 212.00 (+2.80), VRX: 142.14 (+5.41), ACT: 260.06 (+12.12)

Actavis Nabs Allergan For $66 Billion; Valeant Folds
at Investor's Business Daily - Mon Nov 17, 9:17AM CST
One of the most widely rumored deals in pharma came to fruition Monday, as Actavis (ACT) agreed to acquire Allergan (AGN) for $66 billion in cash and stock. Allergan stock was up more than 7%, near 213, and Actavis stock up nearly 4%, near 253, in...
AGN: 212.00 (+2.80), VRX: 142.14 (+5.41), ACT: 260.06 (+12.12)

Time to move on: Valeant chief says $219 too rich
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:13AM CST

ACT: 260.06 (+12.12), VRX: 142.14 (+5.41)

Valeant Comments On Allergan Announcement
PR Newswire - Mon Nov 17, 8:29AM CST
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today commented on the announcement that Allergan, Inc. (NYSE: AGN) and Actavis plc (NYSE: ACT) have entered into a definitive agreement under which Actavis will acquire all outstanding shares of Allergan stock.
AGN: 212.00 (+2.80), ACT: 260.06 (+12.12), VRX: 142.14 (+5.41), VRX.TO: 160.74 (+6.34)

Stock Futures Set For Weak Open; Halliburton, Baker Hughes Merge
at Investor's Business Daily - Mon Nov 17, 8:12AM CST
Stock futures pointed modestly lower ahead of Monday's open as merger news stirred some of the most notable premarket stock moves. Dow futures sifted 27.7 points below fair market value. Nasdaq 100 futures were 9.1 points lower, and S&P 500 futures...
AGN: 212.00 (+2.80), HAS: 55.99 (-0.38), VRX: 142.14 (+5.41), ACT: 260.06 (+12.12), HAL: 49.78 (+0.55), DIS: 90.57 (+0.16), DWA: 22.25 (-0.06), BHI: 65.98 (+0.75)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PACS Group Faces Legal Scrutiny: What to Watch

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

HONA Faces Legal Heat: Investor Lawsuit Over Losses

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

CVS Health Under Fire: Fiduciary Duty Breach?

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Farm Aid 2026: A Resilient Tribute to Family Farmers

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Jackson Wang's Fantasy IP Hits Hong Kong Stage

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

AST SpaceMobile Faces Class Action Over Misstatements

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Geron Corp Faces Fiduciary Duty Investigation

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Cut Winter Heating Costs with Townsend's Rebate Help

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

China Southern Airlines Marks 70th Anniversary in NYC

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Endurance Energy's Modular Tech Revs Up Southeast Asia

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...